AdaptHealth Corp.
About AdaptHealth Corp.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $3.2B
- Net income
- -$70.8M
- Total assets
- $4.3B
- Market cap
- $1.3B
- Gross margin
- 18.8%
- Operating margin
- 2.8%
- Net margin
- -2.0%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $3.2B
- Cost of revenue
- $2.6B
- Gross profit
- $609.2M
- Operating expenses
- $518.3M
- Operating income
- $90.9M
- Income tax
- $50.9M
- Net income
- -$66.0M
- EPS (basic)
- $-0.52
- EPS (diluted)
- $-0.52
Balance sheet
- Total assets
- $4.3B
- Current assets
- $728.9M
- Total liabilities
- $2.8B
- Current liabilities
- $712.4M
- Shareholders’ equity
- $1.5B
Cash flow
- Operating cash flow
- $601.8M
- Investing cash flow
- -$303.2M
- Financing cash flow
- -$302.2M
- Net cash flow
- -$3.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $1.3B
- EPS (diluted)
- $-0.52
- Shares outstanding
- 139.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 16, 2018
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $70.8M in FY2025.
- Revenue grew 32% from FY2021 to FY2025.
- Gross margin of 18.8%, net margin -2.0%.
- Trading 28% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review AdaptHealth Corp..
Write a review
News about AdaptHealth Corp.
News & sentiment via Polygon.io
